OrbiMed Advisors »

IsoRay shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of IsoRay (CATX) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in IsoRay

Tip: Access up to 7 years of quarterly data

All positions including IsoRay held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IsoRay by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.7M 6.5M 1.19

More positions owned by OrbiMed Advisors

Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Edgewise Therapeutics (EWTX)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Biogen Idec (BIIB)
Merck & Co (MRK)
Janux Therapeutics (JANX)
Enliven Therapeutics (ELVN)
Tenet Healthcare Corp Com New (THC)
BioMarin Pharmaceutical (BMRN)
Alpine Immune Sciences (ALPN)
Disc Medicine (IRON)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding IsoRay

Deerfield Management Company
Commodore Capital
Marshall Wace
Vanguard Group
Octagon Capital Advisors
Point72 Asset Management
Henderson Group
Sphera Funds Management
Citadel Advisors
Hills Bank And Trust Company
Laurion Capital Management
Silverarc Capital Management
BlackRock
OrbiMed Advisors
Ghost Tree Capital

View all funds holding IsoRay